Contact this trialFirst, we need to learn more about you.
Virus Therapy
ITI-3000 for Neuroendocrine Carcinoma
Recruiting1 awardPhase 1
Seattle, Washington
This trial will test ITI-3000, a possible treatment for polyomavirus-positive Merkel cell carcinoma (MCC). It will measure how safe and tolerated the drug is, as well as its ability to provoke an immune response.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.